Noble Biomaterials, manufacturer of antimicrobial and anti-odor technologies for performance fabrics announced it has received bluesign® Product Line Approval for its XT2™ technology. Through a comprehensive biocidal product review process, Noble demonstrated that the XT2™ product line meets bluesign® requirements for durability, adherence, efficacy, and low human toxicity, among other quality and safety performance measures.
“This next milestone in our partnership with bluesign® demonstrates our continued commitment to sustainability,” said Jeff Keane, CEO, Noble Biomaterials. “As a leader in odor management, it’s our mission to not only deliver the performance and durability consumers expect, but also align with environmental and social impact best practice.”
[…] read more